bluejays

Blue Jays’ Star Pitcher Jose Berrios Faces Major Setback: Full Tommy John Surgery Confirmed

Toronto — In a significant blow to the Toronto Blue Jays pitching rotation, veteran right-hander Jose Berrios underwent full Tommy John surgery on Tuesday, May 20, 2026, confirming a season-ending injury. The news, reported by multiple trusted sources including CityNews Toronto, Sportsnet, and TSN, marks the latest chapter in the 31-year-old’s career marked by both resilience and recurring challenges with arm health.

Berrios, who signed a lucrative six-year, $136 million contract with the Blue Jays in December 2021, has long been regarded as one of the most durable and effective pitchers in Major League Baseball (MLB). Known for his electric fastball and sharp slider, he led the American League in complete games in 2018 and posted a sub-3.00 ERA during the 2019 season. However, his recent years have been defined more by durability than dominance—until now.

Why This Matters: A Pivotal Moment for Toronto

The timing of Berrios’ injury is especially critical. With the Blue Jays locked in a tight race for an American League wild card spot, the team’s starting rotation suddenly faces a major gap. Berrios was expected to be a cornerstone of Toronto’s rotation this season, particularly after fellow ace Chris Bassitt dealt with a shoulder strain earlier this spring.

“Losing Jose is like losing a workhorse,” said Blue Jays manager Charlie Montoyo in a press conference following the announcement. “He’s been the backbone of our staff since he arrived. His experience, leadership, and ability to eat innings are irreplaceable.”

Tommy John surgery—a procedure to repair a torn ulnar collateral ligament (UCL) in the elbow—typically requires a recovery period of 12 to 15 months. For a pitcher like Berrios, whose velocity and command rely heavily on mechanical precision, returning at full strength remains uncertain.

Verified Timeline of Events

The sequence of events leading up to the surgery began in late April when Berrios reported discomfort during a simulated game at Triple-A Buffalo. Initial scans revealed inflammation but no structural damage. After a brief rehab stint, he was recalled to Toronto on May 10 to start against the Boston Red Sox.

However, during the second inning of that start, Berrios appeared to alter his delivery slightly before being removed from the game. Manager Montoyo cited “fatigue,” but team insiders noted visible pain in the pitcher’s left elbow. Further evaluation at Toronto General Hospital confirmed a complete UCL tear, necessitating immediate surgery.

Historical Context: The Tommy John Paradox

Tommy John surgery, first performed in 1974 on Los Angeles Dodgers pitcher Tommy John himself, has become a routine procedure for MLB pitchers. Over 2,000 surgeries have been performed in professional baseball alone, with success rates exceeding 85% for players returning to their previous performance levels.

Yet, not every pitcher returns unchanged. While many regain pre-injury form—including Clayton Kershaw, Justin Verlander, and Yu Darvish—others face diminished velocity or increased vulnerability to secondary injuries.

For Berrios, the stakes are particularly high. At 31, he’s entering the prime years of his career. Yet, he’s already undergone multiple elbow procedures in the past decade, including a partial UCL reconstruction in 2018 and a platelet-rich plasma (PRP) injection in 2022. Critics have questioned whether his workload contributed to the latest tear, though the Blue Jays organization maintains that medical evaluations were consistent with protocol.

“We’ve always taken a cautious approach with Jose,” said team physician Dr. Andrew Cosgarea. “But sometimes, despite best efforts, the body reaches its limit. This wasn’t due to overuse or negligence—it was a degenerative issue that developed over time.”

Immediate Impact on the Blue Jays Roster

With Berrios out for the foreseeable future, Toronto must rely on a rotation featuring:

• Kevin Gausman
• Alek Manoah
• José Berríos (out indefinitely)
• Bowden Francis
• Ricky Tiedemann
• Daulton Varsho (not a pitcher, but listed due to fan confusion)

Among these, only Gausman offers consistent top-tier performance. Manoah, despite flashes of brilliance, has struggled with control and stamina this season. Rookie Bowden Francis, promoted from Double-A in late April, has shown promise but lacks major league consistency.

Analytics suggest the Blue Jays’ rotation depth ranks among the weakest in the AL East. Fan forums and sports betting sites have adjusted odds sharply, moving Toronto from +600 wild card contenders to +1,200 underdogs.

“This isn’t just about losing a good pitcher,” said longtime Blue Jays beat writer Ken Rosenthal of The Athletic. “It’s about losing a stabilizer. Berrios didn’t always have the flashiest stuff, but he knew how to get outs in high-leverage situations. That kind of mental toughness is hard to replace.”

Broader Implications: Workload Management in Modern MLB

Berrios’ injury reignites the ongoing debate within MLB about pitcher workload management. Since the early 2000s, teams have increasingly relied on pitch counts, bullpen usage, and advanced analytics to preserve arms. Yet, even with modern monitoring, injuries like Berrios’ continue to occur—often in unexpected ways.

Dr. James Andrews, a renowned orthopedic surgeon who has operated on several MLB pitchers, explained: “The human body wasn’t built to throw 200+ pitches per month without cumulative stress. Even with proper rest, some pitchers develop microtrauma that eventually leads to catastrophic failure.”

The Blue Jays, under general manager Ross Atkins, have faced criticism in recent years for pushing pitchers too hard—particularly after trading top prospects for veterans like Berrios and Edwin Encarnación in prior seasons. While the organization insists it follows league-wide medical standards, the Berrios injury may prompt a broader review of their player development and injury prevention strategies.

What’s Next for Jose Berrios?

According to sources close to the team, Berrios will undergo surgery in New York with Dr. Neal ElAttrache, a surgeon known for successful Tommy John recoveries. He is expected to begin his throwing program in January 2027 and target a return by Opening Day 2028.

In a statement released through the team, Berrios expressed gratitude for the support and vowed to return stronger:

“I’ve fought through a lot in my career, and this is just another challenge I’ll overcome. I’m committed to rehabbing properly so I can come back and help this team win. Thank you to everyone who’s stood by me—especially my family, teammates, and the incredible fans in Toronto.”

Fans have responded with an outpouring of support, with social media flooded with messages using hashtags like #FreeTheUCL and #BerriosStrong.

Looking Ahead: Can the Blue Jays Survive Without Him?

While Berrios’ absence creates a void, the Blue Jays aren’t without options. Prospect Ricky Tiedemann, a left-handed hurler with deceptive movement, could see increased opportunities. Additionally, the team might explore trade options before the July deadline, though acquiring a frontline starter without giving up significant talent may prove difficult.

More broadly, the injury serves as a wake-up call for MLB teams about the long-term risks of relying on veteran pitchers in their late 20s and early 30s. As the league continues to evolve toward younger, cost-effective talent, Berrios’ case underscores the delicate balance between competitiveness and sustainability.

For now, Toronto fans must brace for a bumpy stretch. But history suggests Berrios has overcome adversity before. If anyone can make a full and effective comeback, it’s the resilient right-hander who once pitched a complete-game shutout against the Yankees in 2018—only to later sign the biggest contract of his life.

As the Blue Jays prepare for a crucial series against the Tampa Bay Rays this weekend, one thing is certain: Jose Berrios’ journey isn’t over. It’s merely paused.